Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) EBT Margin (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed EBT Margin for 6 consecutive years, with 784.57% as the latest value for Q4 2025.

  • Quarterly EBT Margin changed N/A to 784.57% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1795.4% through Dec 2025, up 157946.0% year-over-year, with the annual reading at 1795.53% for FY2025, 157933.0% up from the prior year.
  • EBT Margin for Q4 2025 was 784.57% at Relay Therapeutics, up from 10301.62% in the prior quarter.
  • The five-year high for EBT Margin was 8349600.0% in Q4 2023, with the low at 82765.55% in Q2 2023.
  • Average EBT Margin over 5 years is 504787.62%, with a median of 11099.31% recorded in 2021.
  • The sharpest move saw EBT Margin plummeted -91371469bps in 2021, then surged 837627154bps in 2023.
  • Over 5 years, EBT Margin stood at 11897.0% in 2021, then plummeted by -124bps to 26671.54% in 2022, then soared by 31405bps to 8349600.0% in 2023, then plummeted by -100bps to 813.55% in 2024, then increased by 4bps to 784.57% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 784.57%, 10301.62%, and 1003.46% for Q4 2025, Q2 2025, and Q1 2025 respectively.